Halozyme Therapeutics
HALO
#1995
Rank
HK$61.33 B
Marketcap
HK$496.53
Share price
-0.99%
Change (1 day)
55.97%
Change (1 year)

Halozyme Therapeutics (HALO) Fails to deliver data

Key failure to deliver metrics for Halozyme Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Halozyme Therapeutics (HALO) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Halozyme Therapeutics (HALO) - since 2013

Volume in USD (price x number of shares), data since 2013

Halozyme Therapeutics (HALO) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025HK$6.18 M-74.12%
2024HK$23.89 M-6.29%
2023HK$25.5 M-15.59%
2022HK$30.2 M38.39%
2021HK$21.82 M-6.23%
2020HK$23.27 M-44.23%
2019HK$41.74 M591.9%
2018HK$6.03 M-64.48%
2017HK$16.98 M-5.65%
2016HK$17.99 M-13.05%
2015HK$20.7 M-7.81%
2014HK$22.45 M140.61%
2013HK$9.33 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
HK$0.04 MHK$2.39 M๐Ÿ‡บ๐Ÿ‡ธ USA
HK$70.56 MHK$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
HK$22.31 MHK$52.9 M๐Ÿ‡บ๐Ÿ‡ธ USA
HK$32.79 MHK$0.34 B๐Ÿ‡บ๐Ÿ‡ธ USA
HK$6.86 MHK$53.59 M๐Ÿ‡ซ๐Ÿ‡ท France
HK$16.63 MHK$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA